Clinical Science Review: Clinical Correlations with the Human Tumor Cloning Assay

References

• Von Hoff D D, Weisenthal L. in vitro methods to predict for patient response to chemotherapy. Adv Pharmacol Chemother 1980; 17: 133–156
   PubMedGoogle Scholar
• Mattern J, Volm M. Clinical relevance of predictive tests for cancer chemotherapy. Cancer Treat Rev 1982; 9: 267–298
   PubMed Web of Science ®Google Scholar
• Dendy P P. The use of in vitro methods to predict tumor response to chemotherapy. Br J Cancer 1980; 41: 195–198
   Web of Science ®Google Scholar
• McAllister R M, Reed G, Huebner R J. Colonial growth in agar of cells derived from adenovirus-induced hamster tumors. J Natl Cancer Inst 1967; 39: 43–53
   PubMed Web of Science ®Google Scholar
• McAllister R M, Reed G. Colonial growth in agar of cells derived from neoplastic and non-neoplastic tissues of children. Pediatr Res 1968; 2: 356–360
   PubMed Web of Science ®Google Scholar
• Altmann A J, Crussi F G, Rierden W J, et al. Growth of rhabdomyosarcoma colonies from pleural fluids. Cancer Res 1975; 35: 1809–1812
   Web of Science ®Google Scholar
• Hamburger A W, Salmon S E. Primary bioassay of human tumor stem cells. Science 1977; 197: 461–463
   PubMed Web of Science ®Google Scholar
• Salmon S E, Hamburger A W, Soehnlen B, et al. Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs. N Engl J Med 1978; 298: 1321–1327
   PubMed Web of Science ®Google Scholar
• Meyskens F L, Jr, Moon T E, Dana B, et al. Quantitation of drug sensitivity by human metastatic melanoma colony-forming units. Br J Cancer 1981; 44: 787–797
   PubMed Web of Science ®Google Scholar
• Tisman G, Wu S JG. The clinical and laboratory evaluation of a modified tumor stem cell assay for the in vitro determination of human tumor cell drug sensitivity. Proc AACR ASCO 1981; 364
   Google Scholar
• Hager T. Cancer drug sensitivity test has problems. JAMA 1982; 248: 3079–3084
   PubMedGoogle Scholar
• Banerjee T K, Marx J J, Jr, Spencer S K, et al. Human tumor stem cell clonogenic assay sensitivity in malignant tumors and clinical correlation. Wisconsin Med J 1982; 81: 19–22
   PubMedGoogle Scholar
• Salmon S E. Preclinical and clinical applications of chemosen-sitivity testing with a human tumor colony assay. Human Tumor Cloning, S E Salmon, J M Trent. Grune and Strat-ton, New York 1984; 499–508
   Google Scholar
• Mann B D, Kern D H, Giuliano A E, et al. Clinical correlations with drug sensitivities in the clonogenic assay-a retrospective study. Arch Surg 1982; 117: 33–36
   PubMed Web of Science ®Google Scholar
• Von Hoff D D, Casper J, Bradley E, et al. Association between human tumor colony-forming assay results and response of an individual patient's tumor to chemotherapy. Am J Med 1981; 70: 1027–1032
   PubMed Web of Science ®Google Scholar
• Von Hoff D D, Clark G M, Stogdill B J, et al. Prospective clinical trial of a human tumor cloning system. Cancer Res 1983; 43: 1926–1931
   PubMed Web of Science ®Google Scholar
• Bertelsen C A, Sondak V K, Mann B D, et al. Chemosensitivity testing in human solid tumors-a review of 1582 assays with 258 clinical correlations. Cancer 1984; 53: 1240–1245
   PubMed Web of Science ®Google Scholar
• Steel G G. Clonogenic tumor cells. J Cell Physiol 1984; 3(Suppl)21–27
   Google Scholar
• Hug V, Thames H, Johnston D, et al. The true predictive value of the human tumor stem cell assay: Does a workable assay select for treatment responders?. J Clin Oncol 1984; 2: 42–45
   PubMed Web of Science ®Google Scholar
• Mattox D E, Von Hoff D D, Clark G M. Factors that influence growth of head and neck squamous carcinoma in the soft agar cloning assay. Cancer 1984; 53: 1736–1740
   PubMed Web of Science ®Google Scholar
• Bertoncello I, Bradley T R, Campbell S S. Limitations of the clonal agar assay for the assessment of primary human ovarian tumour biopsies. Br J Cancer 1982; 45: 803–811
   PubMed Web of Science ®Google Scholar
• Rey A A, Cupissol D, Ursule E. Prognostic value of the human tumor clonogenic assay (HTCA) in patients with ovarian carcinoma. Intern J Cell Cloning 1983; 1: 289–920
   Google Scholar
• Von Hoff D D, Clark G M, Sarosdy M, et al. Clinical correlations for a human tumor cloning system. 3rd EORTC-NCI New Drug Meeting. Brussels, Belgium 1981
   Google Scholar
• Salmon S E, Alberts D S, Meyskens F L, Jr, . Clinical correlations of in vitro drug sensitivity. Cloning of Human Tumor Stem Cells, S E Salmon, et al. Alan R. Liss Inc, New York 1980; 233–245
   Google Scholar
• Moon T E, Salmon S E, White C S, et al. Quantitative association between in vitro human stem cell assay and clinical response to cancer chemotherapy. Cancer Chemother Pharmacol 1981; 6: 211–218
   PubMed Web of Science ®Google Scholar
• Kern D H, Bertelsen C A, Mann B D, et al. Clinical application of the clonogenic assay. Ann Clin Lab Science 1983; 13: 10–15
   PubMed Web of Science ®Google Scholar
• Salmon S E, Soehnlen B F, Durie B GM, et al. Clinical correlations of drug sensitivity in tumor stem cell assay. Proc AACR ASCO 1979; 340
   Google Scholar
• Alberts D S, Salmon S E, Chen H SG, et al. In vitro clonogenic assay for predicting response of ovarian cancer to chemotherapy. Lancet 1980; 2: 340–342
   PubMed Web of Science ®Google Scholar
• Welander C E, Morgan T M, Homesley H D. Multiple factors predicting responses to combination chemotherapy in patients with ovarian cancers. Human Tumor Cloning, S E Salmon, J M Trent. Grune and Stratton, New York 1984; 521–534
   Google Scholar
• Alberts D S, Leigh S, Surwit E A, . Improved survival of patients with relapsing ovarian cancer treated on the basis of drug selection following human tumor clonogenic assay. Human Tumor Cloning, S E Salmon, J M Trent, et al. Grune and Stratton, New York 1984; 509–519
   Google Scholar
• Dana B, Meyskens F L, Jr, Franks D H, et al. In vitro chemosensitivity of human melanoma tumor stem cells (HMTS) in soft agar and in vitrolin vivo correlations. ASCO. 1980, Abstract 145
   Google Scholar
• Meyskens F L, Jr, Loescher L, Moon T E, et al (1983) A prospective trial of single agent chemotherapy for metastatic malignant melanoma directed by in vitro colony survival in a clonogenic assay. Abstract AACR Annual Meeting, San Diego, California, May 25–28, 1983
   Google Scholar
• Einhom L H, Burgess M A, Vallejos C, et al. Prognostic correlations and response in treatment in advanced metastatic malignant melanoma. Cancer Res 1974; 34: 1995–2004
   PubMed Web of Science ®Google Scholar
• Carney D N, Broder L, Edelstein M, et al. Experimental studies of the biology of human small cell lung cancer. Cancer Treat Rep 1983; 67: 27–35
   PubMedGoogle Scholar
• Von Hoff D D, Hanauske A-R. In vitro drug sensitivity testing of human lung cancer. University of Texas, M.D. Anderson Conference on Cancer. University of Texas Press, Austin, Vol. 28, in press
   Google Scholar
• Mattox D E, Von Hoff D D. In vitro stem ceil assay in head and neck squamous cancer. Am J Surg 1980; 140: 527–530
   PubMedGoogle Scholar
• Mattox D E, Von Hoff D D, Harris L L. Human tumor cloning assay in advanced head and neck cancer-prospective correlative trial. Arch Otolaryngol 1983; 109: 724–726
   PubMed Web of Science ®Google Scholar
• Sandbach J., Von Hoff D D, Clark G, et al. Direct cloning of human breast cancer in soft agar culture. Cancer 1982; 50: 1315–1321
   PubMed Web of Science ®Google Scholar
• Sutherland C M, Mather F J, Carter R D, et al. Breast cancer as analyzed by the human tumor stem cell assay. Surgery 1983; 94: 370–375
   PubMed Web of Science ®Google Scholar
• Aapro M S, Schaefer P, Abele R, . Colony growth and patient survival in primary or metastatic breast cancer-a preliminary analysis. Human Tumor Cloning, S E Salmon, J M Trent, et al. Grune and Stratton, New York 1984; 543–549
   Google Scholar
• Jones S E, Dan J C, Young L, . The clinical usefulness of the human tumor clonogenic assay in breast cancer. Human Tumor Cloning, S E Salmon, J M Trent, et al. Grune and Stratton, New York 1984; 557–561
   Google Scholar
• Hug V, Thames H, Haynes M, . Use of normalized drug sensitivities of human breast tumors for clinical correlations and for comparisons of drug activities. Human Tumor Cloning, S E Salmon, J M Trent, et al. Grune and Stratton, New York 1984; 563–573
   Google Scholar
• Cillo C, Aapro M S, Eliason J F, et al. Methylcellulose clonogenic assay for solid human tumors. Proc AACR 1983; 23: 312
   Google Scholar
• Dittrich C H, Sattelhak E, Jakesz R, . Testing of mammary cancer in the human tumor stem cell assay. Human Tumor Cloning, S E Salmon, J M Trent, et al. Grune and Stratton, New York 1984; 551–555
   Google Scholar
• Durie B GM, Young L A, Salmon S E. Human myeloma in vitro colony growth. Interrelationships between drug sensitivity, cell kinetics, and patient survival duration. Blood 1983; 61: 929–934
   PubMed Web of Science ®Google Scholar
• Hamburger A W, Salmon S E. Primary bioassay of human myeloma stem cells. J Clin Invest 1977; 60: 846–854
   PubMed Web of Science ®Google Scholar
• Buick R N, Till J E, McCulloch E A. Colony assay for proliferative cells circulating in myeloblast leukemia. Lancet 1977; 1: 862–863
   PubMed Web of Science ®Google Scholar
• Park C H, Savin M A, Hoogstraten B, et al. Improved growth of colonies in human acute leukemia with feeding culture method. Cancer Res 1977; 37: 4595–4599
   PubMed Web of Science ®Google Scholar
• Minden M D, Buick R N, McCulloch E A. Separation of blast cells and T-lymphoctye progenitors in the blood of patients with acute myeloblastic leukemia. Blood 1979; 54: 186–195
   PubMed Web of Science ®Google Scholar
• Loewenberg B, Swart K, Hagemejer A. PHA-induced colony formation in acute non-lymphocytic and chronic myeloid leukemia. Leukermia Res 1981; 4: 143–149
   Web of Science ®Google Scholar
• Marie J P, Zittoun R, Thevenin D, et al. PHA-induced blast colonies and kinetic parameters in acute myeloid leukemia. Leuk Res 1982; 6: 63–70
   PubMed Web of Science ®Google Scholar
• Buick R N, Messner H A, Till J E, et al. Cytotoxicity of adriamycin and daunorubicin for normal and leukemic progenitor cells in man. JNCI 1979; 62: 249–255
   PubMed Web of Science ®Google Scholar
• McCulloch E A, Curtis J E, Messner H A, et al. The contribution of blast cell properties to outcome variation in acute myeloblasts leukemia (AML). Blood 1982; 59: 601–608
   PubMed Web of Science ®Google Scholar
• Georgoulias V, Iskandar J L, Amesland F, et al. in vitro sensitivity of myeloblast clonogenic cells to doxorubicin, aclacinomycin A, and 4′-0-tetrapyranyl-doxorubicin: correlations with clinical responses. J Clin Oncol 1984; 2: 1215–1222
   PubMed Web of Science ®Google Scholar
• Park C H, Amare M, Wiernik P H, . In vitro drug sensitivity of leukemia colony-forming cells in acute non-lymphocytic leukemia: Clinical correlation update with various drug exposure methods. Human Tumor Cloning, S E Salmon, M Trent, et al. Grune and Stratton, New York 1984; 619–626
   Google Scholar
• Park C H, Amare M, Morrison F S, et al. Chemotherapy sensitivity assessment of leukemic colony forming cells with in vitro simultaneous exposure to multiple drugs: Clinical correlation in acute nonlymphocytic leukemia. Cancer Treat Rep 1982; 66: 1257–1261
   PubMedGoogle Scholar
• Park C H, Amare M, Savin M A, et al. Prediction of chemotherapy response in human leukemia using in vitro chemotherapy sensitivity test on the leukemic colony-forming cells. Blood 1980; 55: 595–601
   PubMed Web of Science ®Google Scholar
• Miller O, Grover F L, Trinkle J K, et al. Growth of tumor colonies on soft agar is a prognostic factor for patients with lung cancer. Surg Forum 1983; 34: 435–437
   Google Scholar
• Lathan B, Von Hoff D D, Clark G M. Comparison of in vitro prediction and clinical outcome for two anthracene derivatives: Mitoxantrone and bisantrene. Human Tumor Cloning, S E Salmon, J M Trent. Grune and Stratton, New York 1984; 607–619
   Google Scholar
• Ahmann F R, Meyskens F L, Moon T E, et al. In vitro chemo-sensitivities of human tumor stem cells to the phase II drug 4′ -(9-acridinylamino)methanesulfon-m-anisidide and prospective in vitro correlations. Cancer Res 1982; 42: 4495–4498
   PubMed Web of Science ®Google Scholar
• Ludwig C U, Durie B GM, Salmon S E, et al. Tumor growth stimulation in vitro by interferons. Eur J Cancer Clin Oncol 1983; 19: 1625–1632
   PubMedGoogle Scholar
• Strayer D R, Weisband J, Carter W, . Sensitivity of renal cell carcinoma to leukocyte interferon in the human tumor clonogenic assay and clinical correlations. Human Tumor Cloning, S E Salmon, J M Trent, et al. Grune and Stratton, New York 1984; 585–593
   Google Scholar
• Von Hoff D D. “Send this patient's tumor for culture and sensitivity?”. N Engl J Med 1983; 308: 154–155
   PubMed Web of Science ®Google Scholar
• Park C H, Wiernik P H, Morrison F S, et al. Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs. Cancer Res 1983; 43: 2346–2349
   PubMed Web of Science ®Google Scholar
• Ajani J A, Spitzer G, Baker F, . Human tumor cloning assay with prospective clinical correlations and association between in vitro sensitivity and the number of drugs tested. Human Tumor Cloning, S E Salmon, J M Trent, et al. Grune and Stratton, New York 1984; 595–605
   Google Scholar
• Hildebrand-Zanki S U, Kern D H. A new bioassay for in vitro drug stability. Human Tumor Cloning, S E Salmon, J M Trent. Grune and Stratton, New York 1984; 451–458
   Google Scholar
• Bradley E C, Issell B F, Hellman R. The human tumor colony-forming chemosensitivity assay: A biological and clinical review. Invest New Drugs 1984; 2: 59–70
   PubMed Web of Science ®Google Scholar
• Salmon S E, Alberts D S, Durie B GM, et al. Clinical correlations of drug sensitivity in the human tumor stem cell assay. Rec Results Cancer Res 1980; 74: 300–305
   PubMedGoogle Scholar
• Alberts D S, Surwit E A, Leigh S, et al. Improved survival of relapsing ovarian cancer patients using the human tumor stem cell assay to select chemotherapy. Stem Cells 1981; 1: 294–295
   Google Scholar
• Hamburger A W, Salmon S E. Primary bioassay of human myeloma stem cells. J Clin Invest 1977; 60: 846–854
   PubMed Web of Science ®Google Scholar
• Smallwood J A, Morgan G R, Cooper A, et al. Correlations between clonogenicity and prognostic factors in human breast cancer. Br J Surg 1984; 71: 109–111
   PubMed Web of Science ®Google Scholar
• Alberts D S, Mackel C, Pocelinko R, et al. Phase 1 clinical investigation of 9,10-anthracenedicarboxaldehyde-bis [(4,5-dihydro-1 H-imidazol-2-yl)hydrazone] dihydrochloride with correlative in vitro human tumor clonogenic assay. Cancer Res 1982; 42: 1170–1175
   PubMed Web of Science ®Google Scholar
• Fan D, Schneider C, Fan S, . Evaluation of human tumor chemosensitivity in the soft agar assays and its clinical correlation. Human Tumor Cloning, S E Salmon, J M Trent, et al. Grune and Stratton, New York 1984; 660–661
   Google Scholar
• Hamburger A W. Modulation of tumor colony growth by irradiated accessory cells. Human Tumor Cloning, S E Salmon, J M Trent. Grune and Stratton, New York 1984; 53–65
   Google Scholar
• Ludwig R, Alberts D S, Miller T P, et al. Evaluation of anticancer drug schedule dependency using an in vitro human tumor clonogenic assay. Cancer Chemother Pharmacol 1984; 12: 135–141
   PubMed Web of Science ®Google Scholar